Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEBENDAZOLE vs PRAZIQUANTEL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEBENDAZOLE vs PRAZIQUANTEL: Safety Overview

Metric MEBENDAZOLE PRAZIQUANTEL
Total FAERS Reports 440 151
Deaths Reported 28 12
Death Rate 6.4% 7.9%
Hospitalizations 70 42
Average Patient Age 29.5 yrs 36.6 yrs
% Female Patients 68.4% 42.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Dec 29, 1982
Manufacturer Janssen Pharmaceuticals, Inc. Bayer HealthCare Pharmaceuticals Inc.
Route ORAL ORAL
Marketing Status Discontinued Discontinued